QuantiPort partners with patent equity fund, Ideaship, to provide physicians with objective blood volume information
July 10, 2019 - MarketsInsider
QuantiPort announced it has received a seed investment from Ideaship, a patent leveraged venture capital firm that provides patent development capital to early stage startups. The investment will support QuantiPort's patent portfolio development related to its disruptive rapid blood volume measurement technology. Learn more.
GoCheck Kids nabs $6M for iPhone App that detects amblyopia in pre-verbal children
April 25, 2019 - HitConsultant
Used by over 4,500 pediatricians nationwide, GoCheck Kids is the first iPhone app registered with the U.S. Food and Drug Administration to screen for correctable vision impairments in children under the age of six. GoCheck Kids makes early screen affordable, reducing the cost by over 60 percent. The company has raised $6M in Series B funding led by FCA Venture Partners. Learn more.
OHSU doctors and scientists discover MS breakthrough
April 18, 2019 - kgw
A scientific breakthrough provides new hope for millions of people living with multiple sclerosis. The disease causes your immune system to attack the central nervous system, which damages the myelin, a protective sheath that covers nerve cells in the brain and spinal cord. Researchers at OHSU have developed a compound that stimulates the repair of myelin, which no medicines currently on the market could accomplish. Learn more.
Xoma acquires royalty rights to five hematology assets from Aronora, Inc.
April 8, 2019 - GlobeNewswire
XOMA Corporation (NASDAQ: XOMA) announced today it has agreed to acquire the rights to potential royalty payments and a portion of the potential milestone payments associated with five hematology assets from Aronora, Inc., an OHSU startup. Three of the assets are anti-thrombotic candidates that are covered by a collaboration with Bayer, a global leader in hematology therapeutics. Two of the collaboration assets are in early to mid-stages of development and the third is a Phase 2 candidate that is subject to an option. In addition, XOMA agreed to acquire the rights to potential royalty payments and a portion of the potential upfront and milestone payments associated with two unpartnered hematology programs from Aronora. Learn more.
OHSU startup MolecularMD is acquired by ICON
Feb. 21, 2019 - MolecularMD
MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in oncology, announced today that it has been acquired by ICON plc (NASDAQ: ICLR). MolecularMD’s extensive scientific and clinical biomarker experience expands ICON’s capabilities in molecular diagnostic testing and also adds expanded testing platforms, including next-generation sequencing and immunohistochemistry, to ICON’s laboratory service offering. MolecularMD’s specialty central laboratory offering and associated client base extends ICON’s reach into the support of precision medicine programs across all phases of drug – diagnostic co-development. Learn more.
Physician assistant students at Pacific University gain hands-on experience using ReelDx
Nov. 29, 2018 - ReelDx
For Brent Norris, assistant professor at Pacific University, nothing has been more satisfying than combining his love of medicine with his love for teaching. He enjoys working with students in the Master of Science in Physician Assistant Studies program as they prepare for a future professional career. When he arrived at Pacific University in Forest Grove, Oregon, Norris saw that the school had ReelDx available, but it wasn’t being used by most of the faculty. However, once he saw firsthand how easy it was to use and the benefits for students, he quickly incorporated it into his curriculum. “I use ReelDx to demonstrate certain procedures to my students,” said Norris. “Using ReelDx allows me to focus on diagnostics with students, especially with some of the tricky ailments that patients can have.” Learn more.
How OHSU and GE Healthcare are solving a major headache: Patient logistics
Nov. 29, 2018 - Portland Business Journal
Working with GE Healthcare, GE's $19 billion health care business, OHSU created aMission Control Center, a NASA-like hub that displays real-time data on the availability anddemand for beds at three hospitals: OHSU, Tuality Healthcare in Hillsboro and AdventistMedical Center in Southeast Portland. Learn more.
Portland health tech startup finds success pivoting back to its roots
Oct. 18, 2018 - Portland Business Journal
ReelDx provides a library of HIPAA compliant videos to health care educators that allow students to see real-world interactions between patients and providers. ReelDx launched five years ago with a mission to improve health care education by providing teachers with videos of real-world interactions between providers and patients. The business flourished, that is until ReelDx decided to build a second, more technology focused product. Learn more.
Aronora's new blood clot treatment receives FDA Fast Track designation
Sept. 26, 2018 - PR Newswire
Aronora, Inc., a clinical stage OHSU biotechnology startup company developing first-in-class treatments for life-threatening diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for proCase (E-WE thrombin, AB002). This enzyme is intended to reverse blood clot formation without increasing the risk of bleeding. Learn more.
Pediatric vision test GoCheck Kids launches for iPhone
Sept. 5, 2018 - MobiHealth News
Gobiquity Mobile Health (formerly iCheck Health Connection) has launched an iPhone-compatible version of GoCheck Kids, its smartphone-based vision impairment photo screener. Previously available only as a Windows mobile app for a Nokia phone, the FDA-registered software allows pediatricians and other healthcare professionals to screen children aged 6 years and younger for amblyopia without. Designed as a low-cost alternative to dedicated screening hardware, which can cost a practice thousands of dollars to purchase, GoCheck Kids is available through a monthly subscription either as a downloadable app or on a pre-loaded iPhone. Learn more.
Three researchers receive 2018 Biomedical Innovation Program drug discovery awards
August 15, 2018 - OHSU Research News
Three drug discovery projects have been named recipients of the 2018 Biomedical Innovation Program awards. The awards provide funds, project management, and mentorship to facilitate the development of innovative technologies at OHSU and accelerate their translation to the marketplace. See the full list of winners and their abstracts.
Murdock Trust announces record year of giving
July 5, 2018 - East Oregonian
The M.J. Murdock Charitable Trust releases its 2017 annual report on grant awards; the OHSU Foundation received $475K for a magnetic resonance scanner and $59K for OmnEcoil, a prostatic MR imaging and biopsy device. Learn more.
New device offers solution for ringing ears
July 4, 2018 - NBC Nightly News
The Levo System retrains the brain to ignore noise by recreating each patient's unique ringing sounds. A recent study reported improvement after three months. View the full video.
How a $600M jolt could get OHSU's promising AIDS vaccine to market
June 14, 2018 - Portland Business Journal
Tomegavax, which was formed to commercialize Dr. Louis Picker's novel HIV vaccine, struggled to gain traction with investors. Then Vir Biotechnology came along. Learn more.
Inside OHSU's $20M quest to deliver the world's first permanent artificial heart to market
Feb. 28, 2018 - Portland Business Journal
OHSU is one of several cardiac research centers racing to get a total artificial heart to market. While its technology is lauded, a lack of funding could stall the effort. Learn more.
Meet the inventor behind OHSU's permanent artificial heart
Feb. 28, 2018 - Portland Business Journal
Dr. Richard Wampler's newest heart technology could prove a boon both for the sickest patients and for the OHSU Knight Cardiovascular Institute. Learn more.
Innovators meet for the 2017 OHSU Commercialization Conference
Sept. 22, 2017 - OHSU Research News
OHSU scientists find possible roots of severe form of MS
Sept. 18, 2017 - Portland Business Journal
Knight Cancer's Druker on how to go about innovation — and how not to
Sept. 14, 2017 - Portland Business Journal
Portland biotech startup may have the remedy for blood clots
Sept. 7, 2017 - Portland Business Journal
What you need to know about the Oregon-born CRISPR gene-editing breakthrough
Aug. 2, 2017 - Portland Business Journal
OHSU scientists successfully repair genetic mutation in human embryos
Aug. 2, 2017 - Portland Business Journal
At OHSU, healthcare tech is a priority
June 8, 2017 - Innovosource
Researchers moving blood testing from the clinic to the home
April 11, 2017 - OHSU Research News
OCTRI Biomedical Innovation Program, funding for drug discovery
Mar. 3, 2017 - OHSU Research News
OHSU's HIV vaccine technology acquired by Bay Area biotech
Jan. 25, 2017 - The Oregonian
Portland vaccine developer acquired by 'immune programming' startup
Jan. 6, 2017 - Portland Business Journal
David Huang, M.D., Ph.D., receives National Academy of Inventors Award
Dec. 13, 2016 - OHSU Research News
2016 BIP Drug Discovery awardees announced
Jul. 7, 2016 - OHSU Research News
How OHSU's Research Spins Off into Tech Start-Ups
Jun. 24, 2016 - PDX Monthly
OHSU's HIV researcher wins more than $14 million
Jun. 20, 2016 - The Oregonian
Is Portland another Silicon Valley… for Life Sciences?
May 9, 2016 - The Pulse by GE Healthcare
GE Healthcare and OHSU refine their collaboration
Apr. 1, 2016 - Portland Business Journal
OHSU, Intel sign up 2 major cancer centers for ambitious cloud project
Mar. 31, 2016 - Portland Business Journal
Healthtech: Portland startup takes video platform to market
Feb. 23, 2016 - Portland Business Journal
A look at three Oregon health care profs-turned-entrepreneurs
Jan. 15, 2016 - Portland Business Journal
OHSU Spinoff raises $11M to tackle rare brain disease
Jan. 12, 2016 - Portland Business Journal
OCTRI announces 2016 Biomedical Innovation Program award recipients
Jan. 6, 2016 - OHSU Research News
After Intel, OHSU teams with another tech giant to tackle complex research
Nov. 13, 2015 - Portland Business Journal
OHSU Knight Cardiovascular creates company to build first Total Artificial Heart
Nov. 5, 2015 - Portland Business Journal
Apple Announces New ResearchKit Studies for Autism, Epilepsy & Melanoma
Oct. 15, 2015 - Apple, Inc.
New Apple ResearchKit trials focus on epilepsy, autism and skin cancer
Oct. 15, 2015 - Fortune Magazine
Portland startup commercializes OHSU colonoscopy technology
Oct. 9, 2015 - Portland Business Journal
Portland wellness company nets $1.4M NIH grant to help firefighters
Aug. 12, 2015 - Portland Business Journal
Knight Challenge Nets Oregon Health & Science University $1B for Cancer Research
Jun. 25, 2015 - ABC News
OHSU grantees hope to regenerate nerves, create better dental composites and treat breast cancer
Jun. 5, 2015 - Portland Business Journal
First-of-its-kind West Nile virus vaccine now in Phase I clinical trials
May 7, 2015 - OHSU News
OHSU researchers look to patent breakthrough eye test technology
Apr. 21, 2015 - Portland Business Journal
Study shows new technology may improve management of leading causes of blindness
Apr. 20, 2015 - OHSU News
Cover Story: OHSU taps Intel to tackle cancer
Apr. 17, 2015 - Portland Business Journal
Healthtech: Portland Startup will tape your doctor visit so you can watch it later
Apr. 14, 2015 - Portland Business Journal
Report Shows Academia-Industry Technology Transfer Contributed Up to $1.18 Trillion to U.S. Economy Since 1996
Mar. 18, 2015 - Biotechnology Industry Organization
Healthtech: Portland biotech startup forms partnership with pharmaceutical heavyweight
Mar. 6, 2015 - Portland Business Journal
The Pitch: A test to keep the heart pumping
Feb. 13, 2015 - Portland Business Journal
FEI, OHSU expand their partnership for high-powered microscopes
Dec. 15, 2014 - Portland Business Journal
The Pitch: A treatment for severe stroke patients
Dec. 12, 2014 - Portland Business Journal
‘Just pee in a cup’ and other big ideas from OHSU inventors
Nov. 6, 2014 - Portland Business Journal
OHSU conferences aim to bring together inventors, investors and industry
Oct. 28, 2014 - Portland Business Journal
Cover Story: A weight loss pill that could fatten OHSU's wallet
Oct. 3, 2014 - Portland Business Journal
OHSU breaks another record for tech spinoffs
Sept. 19, 2013 - Portland Business Journal
Neuro Kinetics in Tech Transfer Licensing Deal with Oregon Health & Science University
May 16, 2013 - MarketWatch by Wall Street Journal
OHSU Hits Tech Transfer Record
Nov. 23, 2012 - Portland Business Journal
Universities Hitting Tech Transfer Strides
Nov. 21, 2012 - Portland Business Journal
OHSU to Double Tech Transfer Office
Jul. 15, 2011 - Portland Business Journal
MolecularMD adds Two New Clients to Bolster Role as OHSU Tech Transfer Success Story
May 29, 2007 - GenomeWeb